Catherine T. Doherty - Net Worth and Insider Trading
Catherine T. Doherty Net Worth
The estimated net worth of Catherine T. Doherty is at least $12 Million dollars as of 2025-07-22. Catherine T. Doherty is the EVP, Regional Businesses of Quest Diagnostics Inc and owns about 72,495 shares of Quest Diagnostics Inc (DGX) stock worth over $12 Million. Details can be seen in Catherine T. Doherty's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Catherine T. Doherty has not made any transactions after 2025-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Catherine T. Doherty
Catherine T. Doherty Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catherine T. Doherty owns 1 companies in total, including Quest Diagnostics Inc (DGX) .
Click here to see the complete history of Catherine T. Doherty’s form 4 insider trades.
Insider Ownership Summary of Catherine T. Doherty
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
DGX | Quest Diagnostics Inc | 2025-03-05 | SVP & Physician Services Bus. |
Catherine T. Doherty Latest Holdings Summary
Catherine T. Doherty currently owns a total of 1 stock. Catherine T. Doherty owns 72,495 shares of Quest Diagnostics Inc (DGX) as of March 5, 2025, with a value of $12 Million.
Latest Holdings of Catherine T. Doherty
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DGX | Quest Diagnostics Inc | 2025-03-05 | 72,495 | 166.45 | 12,066,793 |
Holding Weightings of Catherine T. Doherty
Catherine T. Doherty Form 4 Trading Tracker
According to the SEC Form 4 filings, Catherine T. Doherty has made a total of 15 transactions in Quest Diagnostics Inc (DGX) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Quest Diagnostics Inc is the sale of 5,370 shares on March 5, 2025, which brought Catherine T. Doherty around $935,078.
Insider Trading History of Catherine T. Doherty
- 1
Catherine T. Doherty Trading Performance
Catherine T. Doherty Ownership Network
Ownership Network List of Catherine T. Doherty
Ownership Network Relation of Catherine T. Doherty

Catherine T. Doherty Owned Company Details
What does Quest Diagnostics Inc do?
Who are the key executives at Quest Diagnostics Inc?
Catherine T. Doherty is the SVP & Physician Services Bus. of Quest Diagnostics Inc. Other key executives at Quest Diagnostics Inc include SVP & Chief Commercial Officer Mark E Delaney , SVP & Clinical Solutions Karthik Kuppusamy , and SVP & Operations J. E. Davis .
Quest Diagnostics Inc (DGX) Insider Trades Summary
Over the past 18 months, Catherine T. Doherty made 7 insider transaction in Quest Diagnostics Inc (DGX) with a net sale of 49,012. Other recent insider transactions involving Quest Diagnostics Inc (DGX) include a net sale of 80,336 shares made by Michael E Prevoznik , a net sale of 8,080 shares made by Karthik Kuppusamy , and a net sale of 2,571 shares made by Mark E Delaney .
In summary, during the past 3 months, insiders sold 1,748 shares of Quest Diagnostics Inc (DGX) in total and bought 0 shares, with a net sale of 1,748 shares. During the past 18 months, 202,015 shares of Quest Diagnostics Inc (DGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 202,015 shares.
Quest Diagnostics Inc (DGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quest Diagnostics Inc Insider Transactions
Catherine T. Doherty Mailing Address
Above is the net worth, insider trading, and ownership report for Catherine T. Doherty. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Catherine T. Doherty's mailing address is: Secaucus Nj 07094.